ResearcherSecond Affiliated Hospital of Nanchang UniversityActive in the last 2 years
Jinfeng Zhu
Matched on ORCID iD 0000-0002-7820-9897; OpenAlex author ID A5000506603. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper
Papers 7
- Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Co-author DOI 10.1186/s13578-024-01213-9↗
- Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinom… Co-author DOI 10.3389/fimmu.2023.1111494↗
- Pan-cancer analysis of Krüppel-like factor 3 and its carcinogenesis in pancreatic cancer. Co-author DOI 10.3389/fimmu.2023.1167018↗
- FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression. Co-author DOI 10.1038/s41419-022-04960-0↗
- Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fonc.2022.799475↗
- LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway. Co-author DOI 10.1016/j.omtn.2021.08.024↗
- Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients. Co-author DOI 10.2147/ott.s275649↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chen Huan Luo · 5 shared papers, 2020–2024 · strength 0.76
- Paper Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 deg… DOI 10.1186/s13578-024-01213-9↗
- Paper Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma. DOI 10.3389/fonc.2022.799475↗
- Paper LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pat… DOI 10.1016/j.omtn.2021.08.024↗
- Qian Huang · 2 shared papers, 2022–2023 · strength 0.38
- Paper Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes i… DOI 10.3389/fimmu.2023.1111494↗
- Paper Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma. DOI 10.3389/fonc.2022.799475↗
- Rongfa Yuan · 2 shared papers, 2022–2024 · strength 0.34
- Paper Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 deg… DOI 10.1186/s13578-024-01213-9↗
- Paper FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabi… DOI 10.1038/s41419-022-04960-0↗
- Leifeng Chen · 2 shared papers, 2022–2024 · strength 0.34
- Paper Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 deg… DOI 10.1186/s13578-024-01213-9↗
- Paper FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabi… DOI 10.1038/s41419-022-04960-0↗
- Jiefeng Zhao · 2 shared papers, 2020–2022 · strength 0.24
- Fanqin Bu · 2 shared papers, 2020–2022 · strength 0.24
- Yeqing Zou · 1 shared paper, 2023 · strength 0.22
- Hua Jiang · 1 shared paper, 2023 · strength 0.22
- Qingqing Li · 1 shared paper, 2023 · strength 0.22
- Hongliang Luo · 1 shared paper, 2022 · strength 0.16
- Zhengming Zhu · 1 shared paper, 2021 · strength 0.16
- Xin Yu · 1 shared paper, 2022 · strength 0.13
- Jun Huang · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.